Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ) just unveiled an update.
Fisher & Paykel Healthcare Corporation Limited reported a record full-year revenue of $2.02 billion for the financial year ending March 31, 2025, marking a 16% increase from the previous year. The company saw significant growth in its hospital consumables and sleep apnea mask segments, with a net profit after tax rising by 43% to $377.2 million. The company invested heavily in research and development, launching new products and expanding its market presence in the United States. The outlook for the 2026 financial year anticipates further revenue growth and improved gross margins, despite potential impacts from US tariffs.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare is a leading designer, manufacturer, and marketer of products and systems used in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide.
For an in-depth examination of FSPKF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue